z-logo
open-access-imgOpen Access
Repurposing fluvoxamine, and other psychiatric medications, for COVID ‐19 and other conditions
Author(s) -
Lenze Eric J.,
Reiersen Angela M.,
Santosh Paramala J.
Publication year - 2022
Publication title -
world psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.51
H-Index - 93
eISSN - 2051-5545
pISSN - 1723-8617
DOI - 10.1002/wps.20983
Subject(s) - fluvoxamine , medicine , repurposing , placebo , randomized controlled trial , exacerbation , psychiatry , fluoxetine , pharmacology , alternative medicine , ecology , receptor , serotonin , biology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here